Company Filing History:
Years Active: 2004-2008
Title: The Innovative Contributions of Osamu Tetsu
Introduction
Osamu Tetsu is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of systems that enhance our understanding of metabolic processes. With a total of 2 patents, Tetsu's work is paving the way for advancements in cellular biology.
Latest Patents
One of Tetsu's latest patents is a mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products. This invention utilizes a two-hybrid system to screen for agents that modulate the ability of a cell to degrade or accumulate a metabolic product. It also allows for the selective killing of a cell or the selective expression of a gene or cDNA in a cell that has a defect in its ability to manage metabolic products. The system comprises a mammalian cell with a nucleic acid encoding a peptide binding domain and an effector gene. It includes two chimeric proteins that interact with metabolic products or ligands, enabling researchers to detect changes in gene expression in response to test agents.
Career Highlights
Osamu Tetsu is affiliated with the University of California, where he continues to engage in groundbreaking research. His work has implications for various fields, including drug development and metabolic disease treatment. Tetsu's innovative approaches are helping to advance our understanding of cellular mechanisms.
Collaborations
Tetsu has collaborated with esteemed colleagues such as Kenichi Wakita and Frank McCormick. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.
Conclusion
Osamu Tetsu's contributions to biotechnology through his patents and research at the University of California highlight the importance of innovation in understanding complex biological systems. His work continues to inspire advancements in the field.